Herein is provided a process for producing renewable products, such as alkenes, from a feedstock of biological origin. The process includes subjecting a feedstock including fatty acid glycerides and optionally free fatty acids, wherein at least one hydrocarbon chain is unsaturated, to esterification reaction in the presence of an alcohol. The ester stream thereby obtained is then fractionated and a fraction including esters of unsaturated C18 fatty acids is subjected to metathesis conditions in the presence of an alkene to obtain metathesis products. Fractionation of the metathesis products includes recovery of at least renewable 1-decene, and unsaturated C10-C15 fatty acid esters.

Herein is provided a process for producing renewable products, such as alkenes, from a feedstock of biological origin. The process includes subjecting a feedstock including fatty acid glycerides and optionally free fatty acids, wherein at least one hydrocarbon chain is unsaturated, to esterification reaction in the presence of an alcohol. The ester stream thereby obtained is then fractionated and a fraction including esters of unsaturated C18 fatty acids is subjected to metathesis conditions in the presence of an alkene to obtain metathesis products. Fractionation of the metathesis products includes recovery of at least renewable 1-decene, and unsaturated C10-C15 fatty acid esters.

Disclosed are a preparation method and application of a 4-methyl-5-vinylthiazolyl polymerized spherical ionic liquid catalyst. The method comprises: preparing a functional ionic liquid monomer successfully by taking 4-methyl-5-vinylthiazole as the matrix, and preparing the polymerized spherical ionic liquid from the monomer. The catalyst combines the advantages of both ionic liquid and the polymer, and has the characteristics of large specific surface area, high catalytic activity, high mass transfer rate, good selectivity, high stability, easy recycling and separating, environmental friendliness, wide industrial application prospect, etc. The spherical ionic liquid is made into a novel catalytic packing and then put into a reactive distillation column for continuous reactive distillation of esterification and transesterification to realize the organic combination of the ionic liquid and the reactive distillation technology, achieving good catalytic activity, high product yield, environmental friendliness, and low corrosivity, which has great significance in realizing an environment-friendly process.

Disclosed are a preparation method and application of a 4-methyl-5-vinylthiazolyl polymerized spherical ionic liquid catalyst. The method comprises: preparing a functional ionic liquid monomer successfully by taking 4-methyl-5-vinylthiazole as the matrix, and preparing the polymerized spherical ionic liquid from the monomer. The catalyst combines the advantages of both ionic liquid and the polymer, and has the characteristics of large specific surface area, high catalytic activity, high mass transfer rate, good selectivity, high stability, easy recycling and separating, environmental friendliness, wide industrial application prospect, etc. The spherical ionic liquid is made into a novel catalytic packing and then put into a reactive distillation column for continuous reactive distillation of esterification and transesterification to realize the organic combination of the ionic liquid and the reactive distillation technology, achieving good catalytic activity, high product yield, environmental friendliness, and low corrosivity, which has great significance in realizing an environment-friendly process.

Provided is a process for depolymerization of a poly(C.sub.2-C.sub.4 alkylene terephthalate), which comprises contacting a poly(C.sub.2-C.sub.4 alkylene terephthalate) with methanol and a catalyst chosen from potassium carbonate, sodium carbonate, magnesium methoxide, 1,8-diazabicyclo[5.4.0]undec-7-ene, and triazabicyclodecene, at a temperature sufficient to effect said depolymerization. The process of the invention can be carried out a substantially lower temperature and requires less methanol than necessary for zinc acetate-catalyzed reactions, and is sufficiently robust to tolerate lower-quality poly(C.sub.2-C.sub.4 alkylene terephthalate) scrap feeds.

Provided is a process for depolymerization of a poly(C.sub.2-C.sub.4 alkylene terephthalate), which comprises contacting a poly(C.sub.2-C.sub.4 alkylene terephthalate) with methanol and a catalyst chosen from potassium carbonate, sodium carbonate, magnesium methoxide, 1,8-diazabicyclo[5.4.0]undec-7-ene, and triazabicyclodecene, at a temperature sufficient to effect said depolymerization. The process of the invention can be carried out a substantially lower temperature and requires less methanol than necessary for zinc acetate-catalyzed reactions, and is sufficiently robust to tolerate lower-quality poly(C.sub.2-C.sub.4 alkylene terephthalate) scrap feeds.

Provided is a process for depolymerization of a poly(C.sub.2-C.sub.4 alkylene terephthalate), which comprises contacting a poly(C.sub.2-C.sub.4 alkylene terephthalate) with methanol and a catalyst chosen from potassium carbonate, sodium carbonate, magnesium methoxide, 1,8-diazabicyclo[5.4.0]undec-7-ene, and triazabicyclodecene, at a temperature sufficient to effect said depolymerization. The process of the invention can be carried out a substantially lower temperature and requires less methanol than necessary for zinc acetate-catalyzed reactions, and is sufficiently robust to tolerate lower-quality poly(C.sub.2-C.sub.4 alkylene terephthalate) scrap feeds.

The present invention relates to a method of producing a compound of formula (I) or a salt of a compound of formula (I). The invention also relates to a compound of formula (I) or a salt of a compound of formula (I) for use in a therapeutic method to achieve one or more therapeutic effects as well as for use in the treatment and/or prevention of certain diseases. Furthermore, the invention provides a pharmaceutical composition comprising one or more compound(s) of formula (I) or salt(s) of compound(s) of formula (I).

The present invention relates to a method of producing a compound of formula (I) or a salt of a compound of formula (I). The invention also relates to a compound of formula (I) or a salt of a compound of formula (I) for use in a therapeutic method to achieve one or more therapeutic effects as well as for use in the treatment and/or prevention of certain diseases. Furthermore, the invention provides a pharmaceutical composition comprising one or more compound(s) of formula (I) or salt(s) of compound(s) of formula (I).

The present invention relates to a method of producing a compound of formula (I) or a salt of a compound of formula (I). The invention also relates to a compound of formula (I) or a salt of a compound of formula (I) for use in a therapeutic method to achieve one or more therapeutic effects as well as for use in the treatment and/or prevention of certain diseases. Furthermore, the invention provides a pharmaceutical composition comprising one or more compound(s) of formula (I) or salt(s) of compound(s) of formula (I).